Mohammed Lakhi

admin

Ecnoglutide: What Can UK Readers Learn From the Trials?

Ecnoglutide is another name appearing in weight-management research. This guide explains its own trial evidence and the limits of overseas approval.

Read More

AOD-9604: What Happened in the Weight-Loss Trials?

AOD-9604 has been studied for obesity, but online claims often leave out the details. This guide explains the human evidence and its limits.

Read More

Mazdutide: What Does Approval in China Mean for the UK?

A medicine’s approval in one country does not settle its status elsewhere. Here is how to read the mazdutide evidence without confusing the two.

Read More

Survodutide: What Do Its Weight-Loss Trials Tell Us?

Survodutide is a separate treatment under development. Read what its obesity research has measured and why trial results need context.

Read More

MOTS-c: What Is Behind the Weight-Loss Claims?

Research into MOTS-c does not all answer the same question. This guide separates studies of the body’s own peptide from claims about taking it.

Read More

CJC-1295 and Ipamorelin: Do the Fat-Loss Claims Add Up?

CJC-1295 and ipamorelin are often discussed together. Evidence for each substance should not be confused with evidence for the combination.

Read More
icon
UK-Prescribing Pharmacists
icon
No GP Appointments Needed
icon
Fast & Discreet Delivery